Kidney/Pancreas: Recipients: Immunosuppression Use


View HTML View PDF
8.6aImmunosuppression Use for Induction, 1995 to 2004 Recipients with Kidney-Pancreas TransplantsTable 8.6a (30 K)
8.6bImmunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Kidney-Pancreas TransplantsTable 8.6b (32 K)
8.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Kidney-Pancreas TransplantsTable 8.6c (29 K)
8.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Kidney-Pancreas TransplantsTable 8.6d (30 K)
8.6eImmunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Kidney-Pancreas TransplantsTable 8.6e (31 K)
8.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Kidney-Pancreas TransplantsTable 8.6f (31 K)
8.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Kidney-Pancreas TransplantsTable 8.6g (31 K)
8.6hPersistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Kidney-Pancreas TransplantsTable 8.6h (33 K)
8.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Kidney-Pancreas TransplantsTable 8.6i (30 K)
15.10Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Kidney-Pancreas TransplantsTable 15.1 (31 K)